We utilized a mass spectrometry (MS)-based approach, to identify proteins upregulated when Fbxo9 expression is lost in tumors and identified various proteins previously shown to participate in cancer-related mechanisms, such as metastasis, proliferation, invasion, and metabolism. The gene discussed is FBXO9; the disease is cancer.